Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia

Clinical Laboratory

Volumn 52, Issue 11-12, 2006, Pages 621-629

  Schoorl, Marianne ^a,b   Schoorl, Margreet ^a   Nubé, Menso J ^a   Bartels, Piet C M ^a  

^a Department of Clinical Chemistry Hematology and Immunology ^*  (Netherlands)

^b Location Alkmaar   (Netherlands)

Author keywords

Erythropoiesis; Hemocytometry; Hemodialysis; Hemoglobin content in reticulocytes; Iron deficiency anemia; Uremia

Indexed keywords

BICARBONATE; ERYTHROPOIETIN; ERYTHROPOIETIN ALPHA; FERRIC HYDROXIDE SUCROSE; FERRITIN; HEME; HEMOGLOBIN; IRON; PROTOPORPHYRIN ZINC; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROCYTE LEVEL; ERYTHROCYTE PARAMETERS; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; REFERENCE VALUE; RETICULOCYTE COUNT; RETICULOCYTE HEMOGLOBIN CONTENT; STATISTICAL SIGNIFICANCE; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; ERYTHROCYTE COUNT; ERYTHROPOIESIS; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; REFERENCE VALUES; RENAL DIALYSIS; RETICULOCYTE COUNT; UREMIA;

EID: 33845367440     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sowade O, Sowade B, Brilla K, et al. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoitin beta (recombinant human erythropoietin) in cardiac surgery patients. Am J Hematol 1997;55:89-96
2. Fishbane S, Kowalski EA, Imbriano LJ, Malsaka JK. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996;7:2654-2657
3. Mittman N, Sreedhara R, Mushnick R, Chattopathyay J, Zelmanovic D, Vaseghi M, Avram MM. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997;30:912-922
4. Bartels PCM, Schoorl M, Schoorl M. Hemoglobinization and functional availability of iron for erythropoiesis in case of thalassemia and iron deficiency anemia. Clin Lab 2006;52:107-114
5. Bhandari S, Turney JH, Brownjohn AM, Norfolk D. Reticulocyte indices in patients with end stage renal disease on hemodialysis. J Nephrol 1998;11:72-82
6. Franck S, Linssen J, Messinger M, Thomas L. Potential utility of Ret-Y in the diagnosis of iron restricted erythropoiesis. Clin Chem 2004;50:1240-1242
7. Marsden JT. Erythropoietin measurement and clinical applications. Ann Clin Biochem 2006;43:97-104
8. Brugnara C. Reticulocyte Cellular Indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000;37:91-130
9. Buttarello M, Temporin V, Ceravolo R, Farina G, Bulain P. The new reticulocyte size parameter (RET-Y) of the Sysmex XE-2100. Am J Clin Pathol 2004;121:489-495
10. Hinzmann R. Iron metabolism, iron deficiency and anaemia. From diagnosis to treatment and monitoring. Sysmex J Int 2003;13:65-73
11. Marticorena LJ, Donnelly S. Red blood cell survival in chronic renal failure. Am J Kidney Dis 2004;44:715-719
12. Kletzmayr J, Sunder-Plassmann G, Hörl WH. High dose intravenous iron: a note of caution. Nephrol Dial Transplant 2002; 17:962-965
13. Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Early predicttion of response to intravenous iron supplementation by reticulocyte hemoglobin content and high fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003;18:370-377
14. Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy H, Van der Dussen DH, Van Dieijen-Visser MP, Hamulyak K, Van der Sande FM, Leunissen KM, Kooman JP. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. J Nephrol 2004;17:107-111
15. Sotirakopoulos N, Tsitsios T, Stambolidou M, Athanasiou G, Peiou M, Kokkinou M, Mavromatidis K. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail 2004;26:179-83
16. Ibrahim FF, Ghanram MM, Ali FM. Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients. Ren Fail 2002;24:779-90
17. Bartels PCM, Schoorl M. Mean corpuscular volume-dependent deviations in red blood cell distribution width between Sysmex NE-8000 and SF-3000. Eur J Clin Chem Clin Biochem 1997;35: 549-550
18. Canavese C, Bergamo D, Ciccone G, Burdese M, Maddalena E, Barbieri S, Thea A, Fop F. Low-dose continuous iron therapy leads to a positive iron balance and decreased serum tranferrin levels in chronic haemodialysis patients. Nephrol Dial Transplant 2004;19:1564-1570
19. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red cell regeneration induced by subcutaneous recombinant human erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993;81:956-964
20. Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Internat 1999;55 (suppl 69):544-548